Literature DB >> 9310278

Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival--4.

R B Singh1, M A Niaz, J P Sharma, R Kumar, V Rastogi, M Moshiri.   

Abstract

In a randomized, placebo-controlled trial, the effects of treatment with fish oil (eicosapentaenoic acid, 1.08 g/day) and mustard oil (alpha-linolenic acid, 2.9 g/day) were compared for 1 year in the management of 122 patients (fish oil, group A), 120 patients (mustard oil, group B), and 118 patients (placebo, group C) with suspected acute myocardial infarction (AMI). Treatments were administered about (mean) 18 hours after the symptoms of AMI in all three groups. The extent of cardiac disease, rise in cardiac enzymes, and lipid peroxides were comparable among the groups at entry into the study. After 1 year total cardiac events were significantly less in the fish oil and mustard oil groups compared with the placebo group (24.5% and 28% vs. 34.7%, p < 0.01). Nonfatal infarctions were also significantly less in the fish oil and mustard oil groups compared with the placebo group (13.0% and 15.0% vs. 25.4%, p < 0.05). Total cardiac deaths showed no significant reduction in the mustard oil group; however, the fish oil group had significantly less cardiac deaths compared with the placebo group (11.4% vs. 22.0%, p < 0.05). Apart from the decrease in the cardiac event rate, the fish oil and mustard oil groups also showed a significant reduction in total cardiac arrhythmias, left ventricular enlargement, and angina pectoris compared with the placebo group. Reductions in blood lipoproteins in the two intervention groups were modest and do not appear to be the cause of the benefit in the two groups. Diene conjugates showed a significant reduction in the fish oil and mustard oil groups, indicating that a part of the benefit may be caused by the reduction in oxidative stress. The findings of this study suggest that fish oil and mustard oil, possibly due to the presence of n-3 fatty acids, may provide rapid protective effects in patients with AMI. However, a large study is necessary to confirm this suggestion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9310278     DOI: 10.1023/a:1007757724505

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  80 in total

Review 1.  Omega 3 fatty acids and cardiovascular disease--fishing for a natural treatment.

Authors:  Jehangir N Din; David E Newby; Andrew D Flapan
Journal:  BMJ       Date:  2004-01-03

Review 2.  The cardiovascular effects of flaxseed and its omega-3 fatty acid, alpha-linolenic acid.

Authors:  Delfin Rodriguez-Leyva; Chantal M C Dupasquier; Richelle McCullough; Grant N Pierce
Journal:  Can J Cardiol       Date:  2010-11       Impact factor: 5.223

3.  Marine macroalgae as sources of polyunsaturated fatty acids.

Authors:  M L Colombo; P Risè; F Giavarini; L DE Angelis; C Galli; C L Bolis
Journal:  Plant Foods Hum Nutr       Date:  2006-06       Impact factor: 3.921

4.  Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition.

Authors:  Lisa D Yee; Joanne L Lester; Rachel M Cole; Julia R Richardson; Jason C Hsu; Yan Li; Amy Lehman; Martha A Belury; Steven K Clinton
Journal:  Am J Clin Nutr       Date:  2010-03-24       Impact factor: 7.045

5.  Suspected research fraud: difficulties of getting at the truth.

Authors:  Caroline White
Journal:  BMJ       Date:  2005-07-30

Review 6.  Extending the cardiovascular benefits of omega-3 Fatty acids.

Authors:  William S Harris
Journal:  Curr Atheroscler Rep       Date:  2005-09       Impact factor: 5.113

Review 7.  Does Supplementation with Omega-3 PUFAs Add to the Prevention of Cardiovascular Disease?

Authors:  Evangelos C Rizos; Moses S Elisaf
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

8.  EPA, but not DHA, decreases mean platelet volume in normal subjects.

Authors:  Yongsoon Park; William Harris
Journal:  Lipids       Date:  2002-10       Impact factor: 1.880

9.  Omega-3 fatty acid supplementation for the prevention of arrhythmias.

Authors:  Mina K Chung
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-09

10.  A dietary agonist of transient receptor potential cation channel V3 elicits endothelium-dependent vasodilation.

Authors:  Scott Earley; Albert L Gonzales; Zarine I Garcia
Journal:  Mol Pharmacol       Date:  2010-01-19       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.